The Priority Review

Tag

Gilead Sciences

2 stories

Stories

  1. Clinical trials

    Gilead posts results of Phase 3 ARTISTRY-2 study of BIC/LEN versus B/F/TAF

    Results for the Phase 3 ARTISTRY-2 study were first posted on ClinicalTrials.gov on November 5, 2026. The study enrolled 577 participants and completed primary data collection on October 27, 2025.

  2. Clinical trials

    Gilead posts results of ARTISTRY-1 bictegravir/lenacapavir study

    The study, enrolling 689 participants, compared bictegravir/lenacapavir to stable baseline regimens in virologically suppressed people with HIV-1. Results were first posted on ClinicalTrials.gov on October 21, 2026.